A selection of major announcements

1. Weimeng Group: Plans to transfer more than 50% of Shanghai Weimeng Culture Media's shares to seek partial or full listing in the domestic capital market

$WEIMOB INC (02013.HK)$According to the announcement, the company is currently making preliminary plans for a potential business restructuring of the company and its subsidiaries to consider transferring more than 50% of the shares of Shanghai Weimeng Culture Media Co., Ltd., a wholly-owned subsidiary of the group, according to the estimated overall valuation of the target company not less than RMB 3.6 billion, and obtained no less than RMB 1.8 billion in cash consideration. It plans to seek partial or total listing of the target company in the domestic capital market through this potential transaction.

2. China Civil Aviation Information Network is profitable. The net profit for 2023 is expected to be about 1.25 to 1.45 billion yuan, an increase of 84%-114% over the previous year

$TRAVELSKY TECH (00696.HK)$According to the announcement, the company expects the Group to obtain a net profit of about 1.25 billion yuan to about 1.45 billion yuan for the year ended December 31, 2023, an increase of 84%-114% over the previous year, mainly due to the sharp increase in the number of civil aviation passengers.

3. China Taibao: Taibao Life Insurance's cumulative original insurance business revenue in 2023 was 233.141 billion yuan, an increase of 4.9% over the previous year

$CPIC (02601.HK)$It was announced that from January 1, 2023 to December 31, 2023, the company's subsidiary Taibao Life Insurance's cumulative original insurance business revenue was 233.141 billion yuan, up 4.9% year on year; Taibao Industrial Insurance's cumulative original insurance business revenue was 19.327 billion yuan, up 11.4% year on year.

4. Shijiyao Group: Magnesium sulfate injection and vortioxetine hydrobromate tablets obtained drug production registration approval

$SSY GROUP (02005.HK)$According to the announcement, the Group has obtained drug production registration approval from the China National Drug Administration for magnesium sulfate injections (20ml: 10g, 10ml: 5g and 2ml: 1g) and vortioxetine hydrobromide tablets (10mg), which fall into Class 3 and Class 4 chemicals, respectively, and are deemed to have passed the consistency evaluation. As an anticonvulsant, magnesium sulfate injection is mainly used for high blood pressure in pregnancy to lower blood pressure and treat preeclampsia and eclampsia. Vortioxetine hydrobromide tablets are mainly used to treat depression in adults.

5. Tencent Holdings spent approximately HK$801 million to repurchase 2.83 million shares on January 16

$TENCENT (00700.HK)$It was announced that on January 16, 2024, it cost approximately HK$801 million to repurchase 2.83 million shares at a repurchase price of HK$280-288.4.

6. Meituan-W spent about HK$400 million to buy back 5.39 million shares on January 16

$MEITUAN-W (03690.HK)$It was announced that on January 16, 2024, a repurchase of 5.39 million shares at a cost of approximately HK$400 million, at a repurchase price of HK$72.75-76.15.

Financial data

$TRAVELSKY TECH (00696.HK)$Fa Yingxi expects net profit of about RMB 1.25 to 1.45 billion yuan in 2023, an increase of 84%-114% year-on-year

Operational data

$CPIC (02601.HK)$: Taibao Life Insurance's cumulative original insurance business revenue in 2023 was 233.141 billion yuan, an increase of 4.9% over the previous year

Company news

$WEIMOB INC (02013.HK)$It is proposed to transfer more than 50% of Shanghai Weimeng Culture Media's shares to seek partial or complete listing in the domestic capital market

$COUNTRY GARDEN (02007.HK)$KPMG Corporate Consulting (China) has been appointed as the main financial advisor for overseas debt restructuring

$SSY GROUP (02005.HK)$: Magnesium sulfate injection and vortioxetine hydrobromide tablets obtained drug production registration approval

$ABC (01288.HK)$: The listing of the US$15 billion medium-term note plan is expected to take effect on January 17

$CGN POWER (01816.HK)$Approve subsidiary companies to carry out foreign exchange derivatives trading business

$WULING MOTORS (00305.HK)$Plans to inject 30 million yuan into Wuling New Energy

$HISENSE HA (00921.HK)$: The two subsidiaries purchased a total of 1.58 billion yuan of Huaxia Wealth Management products

$ASIAINFO TECH (01675.HK)$Proposed share transfer by major shareholders at HK$9.45 per share

$CNBM (03323.HK)$: The proposed transaction for Ningxia Building Materials to absorb and merge China Construction information did not meet the restructuring conditions or information disclosure requirements

$SH ELECTRIC (02727.HK)$: Haobo New Energy plans to invest in the Linxia PV project, with a total investment of 1,339 billion yuan

Equity incentives

$MAOYAN ENT (01896.HK)$Issued approximately 11.234 million shares under the share award scheme

$SINO BIOPHARM (01177.HK)$: A further purchase of 5 million shares by the trustee under the restricted share award scheme

Repurchase cancellation

$TENCENT (00700.HK)$On January 16, it cost approximately HK$801 million to repurchase 2.83 million shares

$MEITUAN-W (03690.HK)$5.39 million shares were repurchased at a cost of approximately HK$400 million on January 16

$AIA (01299.HK)$On January 16, approximately HK$197 million was spent to repurchase 3.1 million shares

$HSBC HOLDINGS (00005.HK)$On January 15, the Hong Kong Stock Exchange spent approximately HK$198 million to repurchase 3.2424 million shares

$TIANLI INT HLDG (01773.HK)$Proposed to repurchase shares in the open market for no more than HK$130 million under a repurchase authorization

$XIAOMI-W (01810.HK)$On January 16, approximately HK$48.22,800 was spent to buy back 3.5 million shares

$KUAISHOU-W (01024.HK)$On January 16, HK$22.125 million was spent to buy back 484,800 shares

$ESR (01821.HK)$On January 16, HK$21.414,400 was spent to buy back 2 million shares

$COSCO SHIP HOLD (01919.HK)$On January 16, approximately HK$16.586,700 was spent to repurchase 2.06 million shares

$WUXI BIO (02269.HK)$On January 16, HK$129.894 million was spent to buy back 428,500 shares

$CHINA MOBILE (00941.HK)$On January 16, 180,000 shares were repurchased at HK$11.9424 million

$TECHTRONIC IND (00669.HK)$On January 16, a total of 500,000 shares repurchased were cancelled

$PRU (02378.HK)$Cancellation of 420,000 shares repurchased on January 15

Personnel changes

$CM BANK (03968.HK)$: Cai Jin asked to resign as employee supervisor